231 related articles for article (PubMed ID: 18391101)
1. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.
Ward NC; Tsai IJ; Barden A; van Bockxmeer FM; Puddey IB; Hodgson JM; Croft KD
Hypertension; 2008 May; 51(5):1393-8. PubMed ID: 18391101
[TBL] [Abstract][Full Text] [Related]
2. The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss.
Ward NC; Croft KD; Puddey IB; Phillips M; van Bockxmeer F; Beilin LJ; Barden AE
J Hypertens; 2014 Jul; 32(7):1495-502; discussion 1502. PubMed ID: 24984178
[TBL] [Abstract][Full Text] [Related]
3. The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension.
Laffer CL; Gainer JV; Waterman MR; Capdevila JH; Laniado-Schwartzman M; Nasjletti A; Brown NJ; Elijovich F
Hypertension; 2008 Mar; 51(3):767-72. PubMed ID: 18227405
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Liu X; Zhao Y; Wang L; Yang X; Zheng Z; Zhang Y; Chen F; Liu H
Kidney Int; 2009 Jun; 75(12):1288-1296. PubMed ID: 19279555
[TBL] [Abstract][Full Text] [Related]
5. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.
Gainer JV; Bellamine A; Dawson EP; Womble KE; Grant SW; Wang Y; Cupples LA; Guo CY; Demissie S; O'Donnell CJ; Brown NJ; Waterman MR; Capdevila JH
Circulation; 2005 Jan; 111(1):63-9. PubMed ID: 15611369
[TBL] [Abstract][Full Text] [Related]
6. CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow.
Williams JS; Hopkins PN; Jeunemaitre X; Brown NJ
J Hypertens; 2011 Oct; 29(10):1913-8. PubMed ID: 21873888
[TBL] [Abstract][Full Text] [Related]
7. Intakes of omega-3 polyunsaturated fatty acids and blood pressure change over time: Possible interaction with genes involved in 20-HETE and EETs metabolism.
Tagetti A; Ericson U; Montagnana M; Danese E; Almgren P; Nilsson P; Engström G; Hedblad B; Minuz P; Orho-Melander M; Fava C; Melander O
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():126-33. PubMed ID: 25986600
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
Powell PK; Wolf I; Jin R; Lasker JM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation.
Saito T; Honda M; Takahashi M; Tsukada C; Ito M; Katono Y; Hosono H; Saigusa D; Suzuki N; Tomioka Y; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Feb; 30(1):119-22. PubMed ID: 25760539
[TBL] [Abstract][Full Text] [Related]
10. The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure.
Fava C; Montagnana M; Almgren P; Rosberg L; Lippi G; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
Hypertension; 2008 Aug; 52(2):373-80. PubMed ID: 18574070
[TBL] [Abstract][Full Text] [Related]
11. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11.
Lasker JM; Chen WB; Wolf I; Bloswick BP; Wilson PD; Powell PK
J Biol Chem; 2000 Feb; 275(6):4118-26. PubMed ID: 10660572
[TBL] [Abstract][Full Text] [Related]
12. A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men.
Fu Z; Nakayama T; Sato N; Izumi Y; Kasamaki Y; Shindo A; Ohta M; Soma M; Aoi N; Sato M; Ozawa Y; Ma Y
J Hypertens; 2008 Mar; 26(3):453-61. PubMed ID: 18300855
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE).
Kim WY; Lee SJ; Min J; Oh KS; Kim DH; Kim HS; Shin JG
Prostaglandins Leukot Essent Fatty Acids; 2018 Apr; 131():6-13. PubMed ID: 29628049
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model??
Cai Y
Kidney Int; 2009 Jun; 75(12):1253-1254. PubMed ID: 19483747
[TBL] [Abstract][Full Text] [Related]
15. 20-HETE and blood pressure regulation: clinical implications.
Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
[TBL] [Abstract][Full Text] [Related]
16. CYP4A11 gene T8590C polymorphism is associated with essential hypertension in the male western Chinese Han population.
Yang H; Fu Z; Ma Y; Huang D; Zhu Q; Erdenbat C; Xie X; Liu F; Zheng Y
Clin Exp Hypertens; 2014; 36(6):398-403. PubMed ID: 24164311
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
Kawamura M; Kobashi Y; Tanaka H; Bohno-Mikami A; Hamada M; Ito Y; Hirata T; Ohara H; Kojima N; Koretsune H; Gunji E; Fukunaga T; Inatani S; Hasegawa Y; Suzuki A; Takahashi T; Kakinuma H
J Med Chem; 2022 Nov; 65(21):14599-14613. PubMed ID: 36318660
[TBL] [Abstract][Full Text] [Related]
18. Association of a CYP4A11 variant and blood pressure in black men.
Gainer JV; Lipkowitz MS; Yu C; Waterman MR; Dawson EP; Capdevila JH; Brown NJ;
J Am Soc Nephrol; 2008 Aug; 19(8):1606-12. PubMed ID: 18385420
[TBL] [Abstract][Full Text] [Related]
19. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction.
Mayer B; Lieb W; Götz A; König IR; Kauschen LF; Linsel-Nitschke P; Pomarino A; Holmer S; Hengstenberg C; Doering A; Loewel H; Hense HW; Ziegler A; Erdmann J; Schunkert H
J Hypertens; 2006 Oct; 24(10):1965-70. PubMed ID: 16957555
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CMV and KAP promoters for driving the expression of human CYP4F2 in transgenic mice.
Lai G; Liu X; Wu J; Liu H; Zhao Y
Int J Mol Med; 2012 Jan; 29(1):107-12. PubMed ID: 21887457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]